Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,130.8
-8.8 (-0.28%)

 

  • STI Straits Times Index
    3,130.8
    -8.8 (-0.28%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,575.0
    -3.4 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,256.2
    -180.6 (-0.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,520.5
    2.2 (0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,967.3
    -323.7 (-1.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,078.6
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 365.3M
  • Value: 303.2M
  • Rise: 82
  • Fall: 131
  • Unch: 550

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.197+0.007
MarcoPolo Marine0.030-
SinoCloud0.001-
OTS Holdings0.285+0.285
Sembcorp Marine0.195-0.001
YZJ Shipbldg SGD1.400-
Yinda Infocomm0.300+0.005
Chasen0.066+0.002
Hong Lai Huat0.101+0.004
Jiutian Chemical0.087-

World Indices

World Indices
Name Last Change
Nasdaq 14,039.7 -33.2
HSI 28,337.2 -99.7
HSCEI 10,520.9 -42.1
Jakarta 6,063.5 -15.0
Nikkei 225 28,949.4 -341.6
SSE Comp 3,517.1 -1.2
Shanghai A 3,686.5 -1.3
Shanghai B 251.1 -1.7
KOSPI 3,257.6 -21.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GENMAB AS SPON ADS EACH REP 0.1 ORD SHS GENMAB AS SPON ADS EACH REP 0.1 ORD SHS
Updated on 16 Jun 2021 (End of trading day)
Last (USD): 44.570 Change: +0.550 High: 44.920 Remarks: -
Change (%): +1.25 Low: 43.959
Open 43.960 Yesterday's Close 44.02
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 798,463 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.10880 Trailing EPS (USD) e 1.29925 NAV (USD) b 4.8393
PE a 40.197 Trailing PE f 34.304 Price / NAV b 9.2100
Dividend (USD) d - Cash In Hand (USD) g 1.9006 Issued & Paid-up Shares c 656,207,000
Dividend Yield (%) d - Price / Cash In Hand g 23.450 Treasury Shares h 2,029,770
Market Cap (M) 29,247.146 Enterprise Value (M) 26,449.241
Piotroski F Score 6 Exchange Code GMAB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 37.22 Free Float (%) -
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 07 May 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 29,247.146 40.197 34.304 9.2100 -
Industry Medical Specialties NASDAQ 3,352.058 160.633 153.684 9.2312 0.026
Local Peer INTUITIVE SURGICAL INC NASDAQ 103,187.456 97.292 87.939 10.1627 -
Local Peer IDEXX LABORATORIES INC NASDAQ 50,615.801 87.002 75.075 72.0309 -
Local Peer DEXCOM INC NASDAQ 39,045.007 79.102 75.963 20.5154 -
Local Peer NOVOCURE LTD NASDAQ 22,812.908 1,151.718 1,945.166 61.3033 -
Local Peer INSULET CORPORATION NASDAQ 18,522.138 2,723.809 2,081.139 31.6455 -
Local Peer HOLOGIC INC NASDAQ 15,858.260 14.220 8.315 4.1794 -
Local Peer DENTSPLY SIRONA INC NASDAQ 14,304.195 - 82.255 2.9032 0.612
Local Peer ABIOMED INC NASDAQ 13,738.277 60.917 60.917 10.3321 -
Local Peer MASIMO CORPORATION NASDAQ 12,348.140 51.386 53.868 9.2974 -
Local Peer BRUKER CORPORATION NASDAQ 11,211.039 71.046 54.956 11.5852 0.217
Local Peer STAAR SURGICAL CO NASDAQ 6,939.068 1,173.527 628.596 32.3991 -
Local Peer SOTERA HEALTH CO NASDAQ 6,766.250 - - 14.6058 -
Other Local Peers SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), QUIDEL CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), INMODE LTD (NASDAQ), VERICEL CORP (NASDAQ), AXONICS INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), EARGO INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), DERMTECH INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), 908 DEVICES INC (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), BIOVENTUS INC (NASDAQ), CERUS CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SURMODICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ANTARES PHARMA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), NEUROPACE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ZYNEX INC (NASDAQ), PAVMED INC (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SIENTRA INC (NASDAQ), NEURONETICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), QUOTIENT LTD (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), PROFOUND MED CORP (NASDAQ), IRADIMED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), DARIOHEALTH CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CORMEDIX INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CONFORMIS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), LUCIRA HEALTH INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), TELA BIO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), IRIDEX CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), CELSION CORPORATION (NASDAQ), BIOLASE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), LENSAR INC (NASDAQ), NEPHROS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), APPLIED UV INC (NASDAQ), ELECTROCORE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), DYNATRONICS CORP (NASDAQ), CYANOTECH CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 195,556.809 43.719 34.332 5.8267 1.386
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 184,102.176 28.879 23.233 5.2514 0.190
Global Peer DANAHER CORP NYSE 174,567.902 49.734 49.734 4.6989 0.293
Global Peer MEDTRONIC PLC NYSE 168,201.908 46.645 46.645 3.2706 1.856
Global Peer STRYKER CORP NYSE 96,598.187 60.412 68.607 7.1544 0.917
Global Peer BECTON DICKINSON & CO NYSE 69,877.989 91.106 42.609 2.8149 1.328
Global Peer EDWARDS LIFESCIENCES CORP NYSE 62,250.729 75.602 73.150 13.3630 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 60,786.530 - 425.081 3.8671 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 49,135.890 36.312 36.312 3.3832 1.903
Global Peer AGILENT TECHNOLOGIES INC NYSE 43,571.380 60.600 47.104 9.0585 0.506
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), MICROPORT (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CARDIOFLOW-B (HKEx), EBOS GROUP (ASX), CONMED CORP (NYSE), VENUS MEDTECH-B (HKEx), GLAUKOS CORPORATION (NYSE), HAEMONETICS CORP (NYSE), LIFETECH SCI (HKEx), PEIJIA-B (HKEx), SUPERMX (Bursa), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), NANOSONICS LIMITED (ASX), CIRC (HKEx), CHUNLI MEDICAL (HKEx), CRYOLIFE INC (NYSE), MODERN DENTAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), KDL MEDICAL (HKEx), BASECARE-B (HKEx), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), MCP INCOME OPPORTUNITIES TRUST (ASX), Medtecs Intl (SGX), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTH (HKEx), INVACARE CORP (NYSE), UGHealthcare (SGX), MEDICAL DEVELOPMENT INTL (ASX), AROA BIOSURGERY LTD (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), CYCLOPHARM LIMITED (ASX), PW MEDTECH (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), VINCENT MED (HKEx), SOMNOMED LIMITED (ASX), OPTISCAN IMAGING (ASX), IMPEDIMED LIMITED (ASX), ALPHA PRO TECH (NYSE American), MICRO-X LTD (ASX), KELFRED (HKEx), CLEANSPACE HOLDINGS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), VOLITIONRX LIMITED (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), ELECTROMED INC (NYSE American), SDI LTD (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), CARDIEX LTD (ASX), RGTBHD (Bursa), YUNNAN ENERGY (HKEx), RESONANCE HEALTH LTD (ASX), Biolidics (SGX), ADVENTA (Bursa), COMPUMEDICS (ASX), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), LKL (Bursa), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), Yunnan Energy (SGX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), LIFE HEALTHCARE (HKEx), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), OVENTUS MEDICAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), METALICITY LIMITED (ASX), Annica (SGX), DORSAVI LTD (ASX), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.840
+4.31 %
10 Days -+3.980
+9.81 %
20 Days -+6.490
+17.04 %
Medium Term Return 3 Months -+10.960
+32.61 %
6 Months -+4.870
+12.27 %
1 Year -+12.820
+40.38 %
Annualised Return Annualised --
+40.38 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 29.978 - 44.830 Change From 1 Year Low +14.592 % Change From 1 Year Low (%) +48.67
Change From 1 Year High -0.260 % Change From 1 Year High (%) -0.58
2 Years Range 16.240 - 44.830 Change From 2 Years Low +28.330 % Change From 2 Years Low (%) +174.45
Change From 2 Years High -0.260 % Change From 2 Years High (%) -0.58
5 Years Range 16.240 - 44.830 Change From 5 Years Low +28.330 % Change From 5 Years Low (%) +174.45
Change From 5 Years High -0.260 % Change From 5 Years High (%) -0.58
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jun 2021 44.240 44.320 43.970 44.020 468,630 -
14 Jun 2021 43.960 44.390 43.800 44.140 511,582 -
11 Jun 2021 43.230 43.810 43.000 43.740 614,537 -
10 Jun 2021 42.640 43.700 42.580 43.630 459,736 -
09 Jun 2021 42.450 43.060 42.450 42.730 592,024 -
08 Jun 2021 42.000 42.140 41.310 41.570 448,302 -
07 Jun 2021 40.840 41.580 40.770 41.350 451,216 -
04 Jun 2021 40.320 41.100 40.310 40.950 388,603 -
03 Jun 2021 40.020 40.805 39.760 40.640 284,703 -
02 Jun 2021 40.210 40.630 39.960 40.590 312,553 -
01 Jun 2021 40.540 40.580 40.150 40.210 355,617 -
28 May 2021 40.360 41.065 40.350 40.620 390,845 -
27 May 2021 39.610 40.330 39.430 40.260 455,799 -
26 May 2021 40.090 40.370 39.900 40.250 329,405 -
25 May 2021 40.240 40.340 39.690 40.130 484,565 -
24 May 2021 39.670 39.960 39.383 39.490 225,825 -
21 May 2021 39.200 39.480 38.930 39.250 286,503 -
20 May 2021 38.220 38.990 38.180 38.680 217,441 -
19 May 2021 37.790 38.125 37.610 38.080 250,479 -
18 May 2021 38.300 38.450 37.700 37.790 399,490 -
17 May 2021 38.140 38.850 38.000 38.180 629,358 -
14 May 2021 36.950 37.550 36.900 37.080 299,024 -
Summary
Current 2 Weeks
(02 Jun 2021 to 15 Jun 2021)
40.210 44.390 39.760 44.020 4,531,886 -
Previous 2 Weeks
(18 May 2021 to 01 Jun 2021)
38.300 44.390 37.700 40.210 3,395,969 -
4 Weeks from
(20 Apr 2021 to 17 May 2021)
35.900 44.390 35.340 38.180 8,181,023 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.